All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

146

Reset

146 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BRM421Phase 21 trial

    BRIM Biotechnology Inc. · Dry Eye Disease (DED), Keratoconjunctivitis Sicca

  • BTV100Phase 21 trial

    BioTheraVision, Inc. · Dry Eye

  • CPK850Phase 21 trial

    Novartis · Retinitis Pigmentosa

  • CU06-1004Phase 21 trial

    Curacle Co., Ltd. · DME, Diabetic Macular Edema, Diabetic Macular Edema (DME)

  • EG-301Phase 21 trial

    Evergreen Therapeutics, Inc. · Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)

  • ENN0403Phase 21 trial

    EnnovaBio · Diabetic Macular Edema (DME)

  • EXG202Phase 21 trial

    Guangzhou Jiayin Biotech Ltd · Wet Age-related Macular Degeneration

  • famzeretcelhuman retinal progenitor cells, jCellPhase 21 trial

    jCyte, Inc · Retinitis Pigmentosa

  • FWY003Phase 21 trial

    Novartis · Geographic Atrophy Secondary to Age-related Macular Degeneration

  • FXS5626Phase 21 trial

    Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · Active Non-anterior, Non-infectious Uveitis

  • GVB-2001Phase 21 trial

    IVIEW Therapeutics Inc. · Primary Open-Angle Glaucoma (POAG)

  • HX9428Phase 21 trial

    Fujian Haixi Pharmaceuticals Co., Ltd. · Wet Age-related Macular Degeneration (AMD)

  • intraocular implant releasing timololTimoD implantPhase 21 trial

    EyeD Pharma · Glaucoma, Ocular Hypertension

  • INV-102Phase 21 trial

    Invirsa, Inc. · Non-center Involved Diabetic Macular Edema, Non-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy, Diabetic Retinopathy

  • IOV-3001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Ocular Melanoma

  • KH631Phase 21 trial

    Chengdu Origen Biotechnology Co., Ltd. · Age-Related Macular Degeneration

  • KH658Phase 21 trial

    Chengdu Origen Biotechnology Co., Ltd. · Age-related Macular Degeneration

  • KIO-104Phase 21 trial

    Kiora Pharmaceuticals, Inc. · Macular Edema

  • KIO-301Phase 21 trial

    Kiora Pharmaceuticals, Inc. · Retinitis Pigmentosa

  • KUS121Phase 21 trial

    Kyoto Drug Discovery and Development Co., Ltd. · Central Retinal Artery Occlusion

  • NGGT001Phase 21 trial

    NGGT (Suzhou) Biotechnology Co., Ltd. · Bietti Crystalline Corneoretinal Dystrophy

  • OCU400Phase 21 trial

    Ocugen · Retinitis Pigmentosa, Leber Congenital Amaurosis

  • OHB-607Mecasermin RinfabatePhase 21 trial

    OHB Neonatology Ltd. · Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage

  • OpCT-001Phase 21 trial

    BlueRock Therapeutics · Primary Photoreceptor Disease, Retinitis Pigmentosa (RP), Usher Syndrome

  • OXU-001DEXAspheresPhase 21 trial

    Oxular Limited · Diabetic Macular Edema

  • PG043Phase 21 trial

    Alcon Research · Open Angle Glaucoma, Ocular Hypertension

  • PST-611Phase 21 trial

    Eyevensys · Geographic Atrophy, Age - Related Macular Degeneration (AMD)

  • QR-1123Phase 21 trial

    ProQR Therapeutics · Autosomal Dominant Retinitis Pigmentosa, Eye Diseases, Eye Diseases, Hereditary

  • REGN22530Phase 21 trial

    Regeneron · Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT)

  • RO7446603Phase 21 trial

    Roche (Genentech) · Diabetic Macular Edema

  • RO7965032Phase 21 trial

    Roche (Genentech) · Geographic Atrophy Secondary to Age-Related Macular Degeneration

  • RRG001Phase 21 trial

    Shanghai Refreshgene Technology Co., Ltd. · Neovascular Age-related Macular Degeneration

  • SAR402663Phase 21 trial

    Sanofi · Neovascular Age-related Macular Degeneration

  • SNP318Phase 21 trial

    SciNeuro · Diabetic Macular Edema, DME

  • SOM-401Phase 21 trial

    Inflammasome Therapeutics · Geographic Atrophy, Age-Related Macular Degeneration

  • SPVN06Phase 21 trial

    SparingVision · Retinitis Pigmentosa

  • SPVN20Phase 21 trial

    SparingVision · Retinitis Pigmentosa (RP), Rod Cone Dystrophy

  • SUM-191Phase 21 trial

    Senju USA, Inc. · Bacterial Conjunctivitis

  • SYL1801Phase 21 trial

    Sylentis, S.A. · Wet Macular Degeneration, Neovascular Age-related Macular Degeneration, Macular Degeneration

  • T1695Phase 21 trial

    Laboratoires Thea · Moderate to Severe Vernal Keratoconjunctivitis

  • TJO-087Phase 21 trial

    Taejoon Pharmaceutical Co., Ltd. · Dry Eye Syndrome (DES)

  • VG801Phase 21 trial

    VeonGen Therapeutics GmbH · Retinal Dystrophy Due to Biallelic ABCA4 Mutations, Stargardt Disease 1

  • VOY-101Phase 21 trial

    Perceive Biotherapeutics, Inc. · Age-Related Macular Degeneration, Geographic Atrophy, Non-neovascular AMD

  • VP-001Phase 21 trial

    PYC Therapeutics · Retinitis Pigmentosa 11, Retinal Degeneration, Retinal Disease

  • VSJ-110Phase 21 trial

    Vanda Pharmaceuticals · Dry Eye

  • VX-01Phase 21 trial

    Vantage Biosciences Ltd · Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy

NewerPage 3 of 3

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.